The global market for Antiviral Drug Intermediate was valued at US$ 51 million in the year 2024 and is projected to reach a revised size of US$ 77.6 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Antiviral Drug Intermediate Market

An antiviral drug intermediate is a chemical compound used as a precursor in the synthesis of antiviral drugs, playing a crucial role in the development and production of active pharmaceutical ingredients (APIs).

North American market for Antiviral Drug Intermediate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antiviral Drug Intermediate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antiviral Drug Intermediate include Fuxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals Co., Ltd., Shanghai Pharmaceuticals Kangli, Zhejiang Chetou Pharmaceuticals, Tongliao Desheng Bio-tech, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Zhejiang Oma Pharmaceuticals, Aotong Pharmaceuticals, Manus Aktteva Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Intermediate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Intermediate.

The Antiviral Drug Intermediate market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiviral Drug Intermediate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiviral Drug Intermediate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antiviral Drug Intermediate Market Report

Report Metric	Details
Report Name	Antiviral Drug Intermediate Market
Accounted market size in year	US$ 51 million
Forecasted market size in 2031	US$ 77.6 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Lovir Drugs Foscarnet Sodium Adenosine Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Fuxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals Co., Ltd., Shanghai Pharmaceuticals Kangli, Zhejiang Chetou Pharmaceuticals, Tongliao Desheng Bio-tech, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Zhejiang Oma Pharmaceuticals, Aotong Pharmaceuticals, Manus Aktteva Biopharma, AFINE CHEMICALS, AuroMedics, Hari Pharma, Fresenius Kabi, SteriMax
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiviral Drug Intermediate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiviral Drug Intermediate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antiviral Drug Intermediate Market growing?

Ans: The Antiviral Drug Intermediate Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Antiviral Drug Intermediate Market size in 2031?

Ans: The Antiviral Drug Intermediate Market size in 2031 will be US$ 77.6 million.

Who are the main players in the Antiviral Drug Intermediate Market report?

Ans: The main players in the Antiviral Drug Intermediate Market are Fuxiang Pharmaceuticals, Hubei Yitai Pharmaceuticals Co., Ltd., Shanghai Pharmaceuticals Kangli, Zhejiang Chetou Pharmaceuticals, Tongliao Desheng Bio-tech, Hongyuan Pharmaceuticals, Xinxiang Pharmaceuticals, Zhejiang Oma Pharmaceuticals, Aotong Pharmaceuticals, Manus Aktteva Biopharma, AFINE CHEMICALS, AuroMedics, Hari Pharma, Fresenius Kabi, SteriMax

What are the Application segmentation covered in the Antiviral Drug Intermediate Market report?

Ans: The Applications covered in the Antiviral Drug Intermediate Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Antiviral Drug Intermediate Market report?

Ans: The Types covered in the Antiviral Drug Intermediate Market report are Lovir Drugs, Foscarnet Sodium, Adenosine, Other

1 Antiviral Drug Intermediate Market Overview

1.1 Product Definition

1.2 Antiviral Drug Intermediate by Type

1.2.1 Global Antiviral Drug Intermediate Market Value Comparison by Type (2024 VS 2031)

1.2.2 Lovir Drugs

1.2.3 Foscarnet Sodium

1.2.4 Adenosine

1.2.5 Other

1.3 Antiviral Drug Intermediate by Application

1.3.1 Global Antiviral Drug Intermediate Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Antiviral Drug Intermediate Market Size Estimates and Forecasts

1.4.1 Global Antiviral Drug Intermediate Revenue 2020-2031

1.4.2 Global Antiviral Drug Intermediate Sales 2020-2031

1.4.3 Global Antiviral Drug Intermediate Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antiviral Drug Intermediate Market Competition by Manufacturers

2.1 Global Antiviral Drug Intermediate Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antiviral Drug Intermediate Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antiviral Drug Intermediate Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antiviral Drug Intermediate, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antiviral Drug Intermediate, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antiviral Drug Intermediate, Product Type & Application

2.7 Global Key Manufacturers of Antiviral Drug Intermediate, Date of Enter into This Industry

2.8 Global Antiviral Drug Intermediate Market Competitive Situation and Trends

2.8.1 Global Antiviral Drug Intermediate Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antiviral Drug Intermediate Players Market Share by Revenue

2.8.3 Global Antiviral Drug Intermediate Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antiviral Drug Intermediate Market Scenario by Region

3.1 Global Antiviral Drug Intermediate Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antiviral Drug Intermediate Sales by Region: 2020-2031

3.2.1 Global Antiviral Drug Intermediate Sales by Region: 2020-2025

3.2.2 Global Antiviral Drug Intermediate Sales by Region: 2026-2031

3.3 Global Antiviral Drug Intermediate Revenue by Region: 2020-2031

3.3.1 Global Antiviral Drug Intermediate Revenue by Region: 2020-2025

3.3.2 Global Antiviral Drug Intermediate Revenue by Region: 2026-2031

3.4 North America Antiviral Drug Intermediate Market Facts & Figures by Country

3.4.1 North America Antiviral Drug Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antiviral Drug Intermediate Sales by Country (2020-2031)

3.4.3 North America Antiviral Drug Intermediate Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antiviral Drug Intermediate Market Facts & Figures by Country

3.5.1 Europe Antiviral Drug Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antiviral Drug Intermediate Sales by Country (2020-2031)

3.5.3 Europe Antiviral Drug Intermediate Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antiviral Drug Intermediate Market Facts & Figures by Region

3.6.1 Asia Pacific Antiviral Drug Intermediate Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antiviral Drug Intermediate Sales by Region (2020-2031)

3.6.3 Asia Pacific Antiviral Drug Intermediate Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antiviral Drug Intermediate Market Facts & Figures by Country

3.7.1 Latin America Antiviral Drug Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antiviral Drug Intermediate Sales by Country (2020-2031)

3.7.3 Latin America Antiviral Drug Intermediate Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Antiviral Drug Intermediate Market Facts & Figures by Country

3.8.1 Middle East and Africa Antiviral Drug Intermediate Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antiviral Drug Intermediate Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antiviral Drug Intermediate Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antiviral Drug Intermediate Sales by Type (2020-2031)

4.1.1 Global Antiviral Drug Intermediate Sales by Type (2020-2025)

4.1.2 Global Antiviral Drug Intermediate Sales by Type (2026-2031)

4.1.3 Global Antiviral Drug Intermediate Sales Market Share by Type (2020-2031)

4.2 Global Antiviral Drug Intermediate Revenue by Type (2020-2031)

4.2.1 Global Antiviral Drug Intermediate Revenue by Type (2020-2025)

4.2.2 Global Antiviral Drug Intermediate Revenue by Type (2026-2031)

4.2.3 Global Antiviral Drug Intermediate Revenue Market Share by Type (2020-2031)

4.3 Global Antiviral Drug Intermediate Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antiviral Drug Intermediate Sales by Application (2020-2031)

5.1.1 Global Antiviral Drug Intermediate Sales by Application (2020-2025)

5.1.2 Global Antiviral Drug Intermediate Sales by Application (2026-2031)

5.1.3 Global Antiviral Drug Intermediate Sales Market Share by Application (2020-2031)

5.2 Global Antiviral Drug Intermediate Revenue by Application (2020-2031)

5.2.1 Global Antiviral Drug Intermediate Revenue by Application (2020-2025)

5.2.2 Global Antiviral Drug Intermediate Revenue by Application (2026-2031)

5.2.3 Global Antiviral Drug Intermediate Revenue Market Share by Application (2020-2031)

5.3 Global Antiviral Drug Intermediate Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Fuxiang Pharmaceuticals

6.1.1 Fuxiang Pharmaceuticals Company Information

6.1.2 Fuxiang Pharmaceuticals Description and Business Overview

6.1.3 Fuxiang Pharmaceuticals Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Fuxiang Pharmaceuticals Antiviral Drug Intermediate Product Portfolio

6.1.5 Fuxiang Pharmaceuticals Recent Developments/Updates

6.2 Hubei Yitai Pharmaceuticals Co., Ltd.

6.2.1 Hubei Yitai Pharmaceuticals Co., Ltd. Company Information

6.2.2 Hubei Yitai Pharmaceuticals Co., Ltd. Description and Business Overview

6.2.3 Hubei Yitai Pharmaceuticals Co., Ltd. Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Hubei Yitai Pharmaceuticals Co., Ltd. Antiviral Drug Intermediate Product Portfolio

6.2.5 Hubei Yitai Pharmaceuticals Co., Ltd. Recent Developments/Updates

6.3 Shanghai Pharmaceuticals Kangli

6.3.1 Shanghai Pharmaceuticals Kangli Company Information

6.3.2 Shanghai Pharmaceuticals Kangli Description and Business Overview

6.3.3 Shanghai Pharmaceuticals Kangli Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shanghai Pharmaceuticals Kangli Antiviral Drug Intermediate Product Portfolio

6.3.5 Shanghai Pharmaceuticals Kangli Recent Developments/Updates

6.4 Zhejiang Chetou Pharmaceuticals

6.4.1 Zhejiang Chetou Pharmaceuticals Company Information

6.4.2 Zhejiang Chetou Pharmaceuticals Description and Business Overview

6.4.3 Zhejiang Chetou Pharmaceuticals Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Zhejiang Chetou Pharmaceuticals Antiviral Drug Intermediate Product Portfolio

6.4.5 Zhejiang Chetou Pharmaceuticals Recent Developments/Updates

6.5 Tongliao Desheng Bio-tech

6.5.1 Tongliao Desheng Bio-tech Company Information

6.5.2 Tongliao Desheng Bio-tech Description and Business Overview

6.5.3 Tongliao Desheng Bio-tech Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Tongliao Desheng Bio-tech Antiviral Drug Intermediate Product Portfolio

6.5.5 Tongliao Desheng Bio-tech Recent Developments/Updates

6.6 Hongyuan Pharmaceuticals

6.6.1 Hongyuan Pharmaceuticals Company Information

6.6.2 Hongyuan Pharmaceuticals Description and Business Overview

6.6.3 Hongyuan Pharmaceuticals Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hongyuan Pharmaceuticals Antiviral Drug Intermediate Product Portfolio

6.6.5 Hongyuan Pharmaceuticals Recent Developments/Updates

6.7 Xinxiang Pharmaceuticals

6.7.1 Xinxiang Pharmaceuticals Company Information

6.7.2 Xinxiang Pharmaceuticals Description and Business Overview

6.7.3 Xinxiang Pharmaceuticals Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Xinxiang Pharmaceuticals Antiviral Drug Intermediate Product Portfolio

6.7.5 Xinxiang Pharmaceuticals Recent Developments/Updates

6.8 Zhejiang Oma Pharmaceuticals

6.8.1 Zhejiang Oma Pharmaceuticals Company Information

6.8.2 Zhejiang Oma Pharmaceuticals Description and Business Overview

6.8.3 Zhejiang Oma Pharmaceuticals Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Zhejiang Oma Pharmaceuticals Antiviral Drug Intermediate Product Portfolio

6.8.5 Zhejiang Oma Pharmaceuticals Recent Developments/Updates

6.9 Aotong Pharmaceuticals

6.9.1 Aotong Pharmaceuticals Company Information

6.9.2 Aotong Pharmaceuticals Description and Business Overview

6.9.3 Aotong Pharmaceuticals Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Aotong Pharmaceuticals Antiviral Drug Intermediate Product Portfolio

6.9.5 Aotong Pharmaceuticals Recent Developments/Updates

6.10 Manus Aktteva Biopharma

6.10.1 Manus Aktteva Biopharma Company Information

6.10.2 Manus Aktteva Biopharma Description and Business Overview

6.10.3 Manus Aktteva Biopharma Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Manus Aktteva Biopharma Antiviral Drug Intermediate Product Portfolio

6.10.5 Manus Aktteva Biopharma Recent Developments/Updates

6.11 AFINE CHEMICALS

6.11.1 AFINE CHEMICALS Company Information

6.11.2 AFINE CHEMICALS Description and Business Overview

6.11.3 AFINE CHEMICALS Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.11.4 AFINE CHEMICALS Antiviral Drug Intermediate Product Portfolio

6.11.5 AFINE CHEMICALS Recent Developments/Updates

6.12 AuroMedics

6.12.1 AuroMedics Company Information

6.12.2 AuroMedics Description and Business Overview

6.12.3 AuroMedics Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.12.4 AuroMedics Antiviral Drug Intermediate Product Portfolio

6.12.5 AuroMedics Recent Developments/Updates

6.13 Hari Pharma

6.13.1 Hari Pharma Company Information

6.13.2 Hari Pharma Description and Business Overview

6.13.3 Hari Pharma Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Hari Pharma Antiviral Drug Intermediate Product Portfolio

6.13.5 Hari Pharma Recent Developments/Updates

6.14 Fresenius Kabi

6.14.1 Fresenius Kabi Company Information

6.14.2 Fresenius Kabi Description and Business Overview

6.14.3 Fresenius Kabi Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Fresenius Kabi Antiviral Drug Intermediate Product Portfolio

6.14.5 Fresenius Kabi Recent Developments/Updates

6.15 SteriMax

6.15.1 SteriMax Company Information

6.15.2 SteriMax Description and Business Overview

6.15.3 SteriMax Antiviral Drug Intermediate Sales, Revenue and Gross Margin (2020-2025)

6.15.4 SteriMax Antiviral Drug Intermediate Product Portfolio

6.15.5 SteriMax Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antiviral Drug Intermediate Industry Chain Analysis

7.2 Antiviral Drug Intermediate Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antiviral Drug Intermediate Production Mode & Process Analysis

7.4 Antiviral Drug Intermediate Sales and Marketing

7.4.1 Antiviral Drug Intermediate Sales Channels

7.4.2 Antiviral Drug Intermediate Distributors

7.5 Antiviral Drug Intermediate Customer Analysis

8 Antiviral Drug Intermediate Market Dynamics

8.1 Antiviral Drug Intermediate Industry Trends

8.2 Antiviral Drug Intermediate Market Drivers

8.3 Antiviral Drug Intermediate Market Challenges

8.4 Antiviral Drug Intermediate Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Fuxiang Pharmaceuticals

Hubei Yitai Pharmaceuticals Co., Ltd.

Shanghai Pharmaceuticals Kangli

Zhejiang Chetou Pharmaceuticals

Tongliao Desheng Bio-tech

Hongyuan Pharmaceuticals

Xinxiang Pharmaceuticals

Zhejiang Oma Pharmaceuticals

Aotong Pharmaceuticals

Manus Aktteva Biopharma

List of Tables

Table 1. Global Antiviral Drug Intermediate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antiviral Drug Intermediate Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antiviral Drug Intermediate Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antiviral Drug Intermediate Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global Antiviral Drug Intermediate Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antiviral Drug Intermediate Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antiviral Drug Intermediate Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antiviral Drug Intermediate Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antiviral Drug Intermediate, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antiviral Drug Intermediate, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antiviral Drug Intermediate, Product Type & Application

Table 12. Global Key Manufacturers of Antiviral Drug Intermediate, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antiviral Drug Intermediate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Intermediate as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antiviral Drug Intermediate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antiviral Drug Intermediate Sales by Region (2020-2025) & (Tons)

Table 18. Global Antiviral Drug Intermediate Sales Market Share by Region (2020-2025)

Table 19. Global Antiviral Drug Intermediate Sales by Region (2026-2031) & (Tons)

Table 20. Global Antiviral Drug Intermediate Sales Market Share by Region (2026-2031)

Table 21. Global Antiviral Drug Intermediate Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antiviral Drug Intermediate Revenue Market Share by Region (2020-2025)

Table 23. Global Antiviral Drug Intermediate Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antiviral Drug Intermediate Revenue Market Share by Region (2026-2031)

Table 25. North America Antiviral Drug Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antiviral Drug Intermediate Sales by Country (2020-2025) & (Tons)

Table 27. North America Antiviral Drug Intermediate Sales by Country (2026-2031) & (Tons)

Table 28. North America Antiviral Drug Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antiviral Drug Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antiviral Drug Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antiviral Drug Intermediate Sales by Country (2020-2025) & (Tons)

Table 32. Europe Antiviral Drug Intermediate Sales by Country (2026-2031) & (Tons)

Table 33. Europe Antiviral Drug Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antiviral Drug Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antiviral Drug Intermediate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antiviral Drug Intermediate Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific Antiviral Drug Intermediate Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific Antiviral Drug Intermediate Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antiviral Drug Intermediate Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antiviral Drug Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antiviral Drug Intermediate Sales by Country (2020-2025) & (Tons)

Table 42. Latin America Antiviral Drug Intermediate Sales by Country (2026-2031) & (Tons)

Table 43. Latin America Antiviral Drug Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antiviral Drug Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antiviral Drug Intermediate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antiviral Drug Intermediate Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa Antiviral Drug Intermediate Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa Antiviral Drug Intermediate Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antiviral Drug Intermediate Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antiviral Drug Intermediate Sales (Tons) by Type (2020-2025)

Table 51. Global Antiviral Drug Intermediate Sales (Tons) by Type (2026-2031)

Table 52. Global Antiviral Drug Intermediate Sales Market Share by Type (2020-2025)

Table 53. Global Antiviral Drug Intermediate Sales Market Share by Type (2026-2031)

Table 54. Global Antiviral Drug Intermediate Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antiviral Drug Intermediate Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antiviral Drug Intermediate Revenue Market Share by Type (2020-2025)

Table 57. Global Antiviral Drug Intermediate Revenue Market Share by Type (2026-2031)

Table 58. Global Antiviral Drug Intermediate Price (US$/Ton) by Type (2020-2025)

Table 59. Global Antiviral Drug Intermediate Price (US$/Ton) by Type (2026-2031)

Table 60. Global Antiviral Drug Intermediate Sales (Tons) by Application (2020-2025)

Table 61. Global Antiviral Drug Intermediate Sales (Tons) by Application (2026-2031)

Table 62. Global Antiviral Drug Intermediate Sales Market Share by Application (2020-2025)

Table 63. Global Antiviral Drug Intermediate Sales Market Share by Application (2026-2031)

Table 64. Global Antiviral Drug Intermediate Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antiviral Drug Intermediate Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antiviral Drug Intermediate Revenue Market Share by Application (2020-2025)

Table 67. Global Antiviral Drug Intermediate Revenue Market Share by Application (2026-2031)

Table 68. Global Antiviral Drug Intermediate Price (US$/Ton) by Application (2020-2025)

Table 69. Global Antiviral Drug Intermediate Price (US$/Ton) by Application (2026-2031)

Table 70. Fuxiang Pharmaceuticals Company Information

Table 71. Fuxiang Pharmaceuticals Description and Business Overview

Table 72. Fuxiang Pharmaceuticals Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Fuxiang Pharmaceuticals Antiviral Drug Intermediate Product

Table 74. Fuxiang Pharmaceuticals Recent Developments/Updates

Table 75. Hubei Yitai Pharmaceuticals Co., Ltd. Company Information

Table 76. Hubei Yitai Pharmaceuticals Co., Ltd. Description and Business Overview

Table 77. Hubei Yitai Pharmaceuticals Co., Ltd. Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Hubei Yitai Pharmaceuticals Co., Ltd. Antiviral Drug Intermediate Product

Table 79. Hubei Yitai Pharmaceuticals Co., Ltd. Recent Developments/Updates

Table 80. Shanghai Pharmaceuticals Kangli Company Information

Table 81. Shanghai Pharmaceuticals Kangli Description and Business Overview

Table 82. Shanghai Pharmaceuticals Kangli Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Shanghai Pharmaceuticals Kangli Antiviral Drug Intermediate Product

Table 84. Shanghai Pharmaceuticals Kangli Recent Developments/Updates

Table 85. Zhejiang Chetou Pharmaceuticals Company Information

Table 86. Zhejiang Chetou Pharmaceuticals Description and Business Overview

Table 87. Zhejiang Chetou Pharmaceuticals Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Zhejiang Chetou Pharmaceuticals Antiviral Drug Intermediate Product

Table 89. Zhejiang Chetou Pharmaceuticals Recent Developments/Updates

Table 90. Tongliao Desheng Bio-tech Company Information

Table 91. Tongliao Desheng Bio-tech Description and Business Overview

Table 92. Tongliao Desheng Bio-tech Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Tongliao Desheng Bio-tech Antiviral Drug Intermediate Product

Table 94. Tongliao Desheng Bio-tech Recent Developments/Updates

Table 95. Hongyuan Pharmaceuticals Company Information

Table 96. Hongyuan Pharmaceuticals Description and Business Overview

Table 97. Hongyuan Pharmaceuticals Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Hongyuan Pharmaceuticals Antiviral Drug Intermediate Product

Table 99. Hongyuan Pharmaceuticals Recent Developments/Updates

Table 100. Xinxiang Pharmaceuticals Company Information

Table 101. Xinxiang Pharmaceuticals Description and Business Overview

Table 102. Xinxiang Pharmaceuticals Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Xinxiang Pharmaceuticals Antiviral Drug Intermediate Product

Table 104. Xinxiang Pharmaceuticals Recent Developments/Updates

Table 105. Zhejiang Oma Pharmaceuticals Company Information

Table 106. Zhejiang Oma Pharmaceuticals Description and Business Overview

Table 107. Zhejiang Oma Pharmaceuticals Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Zhejiang Oma Pharmaceuticals Antiviral Drug Intermediate Product

Table 109. Zhejiang Oma Pharmaceuticals Recent Developments/Updates

Table 110. Aotong Pharmaceuticals Company Information

Table 111. Aotong Pharmaceuticals Description and Business Overview

Table 112. Aotong Pharmaceuticals Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Aotong Pharmaceuticals Antiviral Drug Intermediate Product

Table 114. Aotong Pharmaceuticals Recent Developments/Updates

Table 115. Manus Aktteva Biopharma Company Information

Table 116. Manus Aktteva Biopharma Description and Business Overview

Table 117. Manus Aktteva Biopharma Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Manus Aktteva Biopharma Antiviral Drug Intermediate Product

Table 119. Manus Aktteva Biopharma Recent Developments/Updates

Table 120. AFINE CHEMICALS Company Information

Table 121. AFINE CHEMICALS Description and Business Overview

Table 122. AFINE CHEMICALS Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. AFINE CHEMICALS Antiviral Drug Intermediate Product

Table 124. AFINE CHEMICALS Recent Developments/Updates

Table 125. AuroMedics Company Information

Table 126. AuroMedics Description and Business Overview

Table 127. AuroMedics Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. AuroMedics Antiviral Drug Intermediate Product

Table 129. AuroMedics Recent Developments/Updates

Table 130. Hari Pharma Company Information

Table 131. Hari Pharma Description and Business Overview

Table 132. Hari Pharma Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Hari Pharma Antiviral Drug Intermediate Product

Table 134. Hari Pharma Recent Developments/Updates

Table 135. Fresenius Kabi Company Information

Table 136. Fresenius Kabi Description and Business Overview

Table 137. Fresenius Kabi Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 138. Fresenius Kabi Antiviral Drug Intermediate Product

Table 139. Fresenius Kabi Recent Developments/Updates

Table 140. SteriMax Company Information

Table 141. SteriMax Description and Business Overview

Table 142. SteriMax Antiviral Drug Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 143. SteriMax Antiviral Drug Intermediate Product

Table 144. SteriMax Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Antiviral Drug Intermediate Distributors List

Table 148. Antiviral Drug Intermediate Customers List

Table 149. Antiviral Drug Intermediate Market Trends

Table 150. Antiviral Drug Intermediate Market Drivers

Table 151. Antiviral Drug Intermediate Market Challenges

Table 152. Antiviral Drug Intermediate Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antiviral Drug Intermediate

Figure 2. Global Antiviral Drug Intermediate Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antiviral Drug Intermediate Market Share by Type: 2024 & 2031

Figure 4. Lovir Drugs Product Picture

Figure 5. Foscarnet Sodium Product Picture

Figure 6. Adenosine Product Picture

Figure 7. Other Product Picture

Figure 8. Global Antiviral Drug Intermediate Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Antiviral Drug Intermediate Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Other

Figure 13. Global Antiviral Drug Intermediate Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Antiviral Drug Intermediate Market Size (2020-2031) & (US$ Million)

Figure 15. Global Antiviral Drug Intermediate Sales (2020-2031) & (Tons)

Figure 16. Global Antiviral Drug Intermediate Average Price (US$/Ton) & (2020-2031)

Figure 17. Antiviral Drug Intermediate Report Years Considered

Figure 18. Antiviral Drug Intermediate Sales Share by Manufacturers in 2024

Figure 19. Global Antiviral Drug Intermediate Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Antiviral Drug Intermediate Players: Market Share by Revenue in Antiviral Drug Intermediate in 2024

Figure 21. Antiviral Drug Intermediate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Antiviral Drug Intermediate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Antiviral Drug Intermediate Sales Market Share by Country (2020-2031)

Figure 24. North America Antiviral Drug Intermediate Revenue Market Share by Country (2020-2031)

Figure 25. United States Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Antiviral Drug Intermediate Sales Market Share by Country (2020-2031)

Figure 28. Europe Antiviral Drug Intermediate Revenue Market Share by Country (2020-2031)

Figure 29. Germany Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Antiviral Drug Intermediate Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Antiviral Drug Intermediate Revenue Market Share by Region (2020-2031)

Figure 36. China Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Antiviral Drug Intermediate Sales Market Share by Country (2020-2031)

Figure 44. Latin America Antiviral Drug Intermediate Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Colombia Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Antiviral Drug Intermediate Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Antiviral Drug Intermediate Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Antiviral Drug Intermediate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Antiviral Drug Intermediate by Type (2020-2031)

Figure 55. Global Revenue Market Share of Antiviral Drug Intermediate by Type (2020-2031)

Figure 56. Global Antiviral Drug Intermediate Price (US$/Ton) by Type (2020-2031)

Figure 57. Global Sales Market Share of Antiviral Drug Intermediate by Application (2020-2031)

Figure 58. Global Revenue Market Share of Antiviral Drug Intermediate by Application (2020-2031)

Figure 59. Global Antiviral Drug Intermediate Price (US$/Ton) by Application (2020-2031)

Figure 60. Antiviral Drug Intermediate Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lovir Drug Intermediate Market Research Report 2025

Global Ritonavir Intermediates Market Research Report 2024

Global Pharmaceutical Intermediates Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Small Molecule API and Intermediates Market Research Report 2024

Advanced Pharmaceutical Intermediates Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Penicillin Intermediate Market Research Report 2025

Global Penicillin Intermediates Market Research Report 2025

Global Diacetylacyclovir Market Research Report 2025

Global Nucleoside Antiviral Active Pharmaceutical Ingredient API Market Research Report 2025

Global Cephalosporin Intermediates Market Research Report 2025

Global Dolutegravir Intermediates Market Research Report 2024

Global Influenza Flu Antiviral Drugs Market Insights Forecast to 2030

Pharmaceutical Fine Chemicals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Acyclovir Active Pharmaceutical Ingredient API Market Research Report 2025

Global Ketoconazole Intermediate Market Research Report 2025

Global Fluorinated Pharmaceutical Intermediates Market Research Report 2025

Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Antiviral Drugs Market

Influenza Antiviral Drugs Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions